← Back to All Filings

Natera Director Files Intent to Sell $2.1M in NTRA Stock

Low SignificanceDecember 17, 2025 at 12:02:07 PM EST

Natera, Inc.

$NTRA144CIK: 0001604821

Subscribe to track NTRA

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Natera Director Files Intent to Sell $2.1M in NTRA Stock

Company: Natera, Inc. (NTRA) Form: 144 | Filed: 2025-12-17 Significance: Low

Insider: Sheena Jonathan Title: Director | Relationship: Director

Transaction (Proposed): • Type: Proposed Sale • Shares: 9,210 • Est. Value: $2,099,880 • Price/Share: ~$228.00

Key Insight: This proposed sale represents a negligible fraction (<0.01%) of the company's market cap and shares outstanding. The sale is part of a pre-arranged 10b5-1 trading plan, reducing its market signaling value.

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: Natera, Inc. (NTRA)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A director filed a notice of intent to sell approximately $2.1 million worth of stock, a transaction of low materiality conducted under a pre-established 10b5-1 trading plan.
  • Market Impact: Neutral, as the sale is very small relative to the company's size and was pre-planned.

Company Information

FieldValue
CompanyNatera, Inc.
Ticker SymbolNTRA
CIK0001604821
IndustrySERVICES-MEDICAL LABORATORIES

Insider Information

FieldValue
NameSheena Jonathan
CIK0001646649
Title/PositionDirector
RelationshipDirector

Transaction Details

FieldValue
Form Type144 (Notice of Proposed Sale)
Transaction Date2025-12-17 (Approximate Sale Date)
Transaction CodeNot Applicable
Security TypeCommon Stock
Shares Involved9,210
Price Per Share~$228.00 (estimated)
Total Value$2,099,880
Shares Owned AfterNot Available
Ownership TypeNot Specified

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$2,099,880
% of Market Cap0.007%
Shares Transacted9,210
% of Shares Outstanding0.007%
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For Natera, a company with a market capitalization of $28.19 billion, this $2.1 million sale is financially immaterial.
  • Transaction Significance: The transaction represents less than 0.01% of both the market capitalization and the total shares outstanding (138,014,465), falling well below the threshold for even moderate significance.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction's size is negligible compared to the company's market value and daily trading volume. Furthermore, its execution under a 10b5-1 plan signifies it was arranged in advance, not based on immediate non-public information.

Volume & Sentiment

  • Expected Volume Impact: Minimal. The number of shares is too small to significantly affect trading volume.
  • Sentiment Indicator: Neutral. Pre-planned sales by insiders for portfolio diversification or liquidity are common and typically do not negatively impact market sentiment.

Additional Context

Special Circumstances

  • This notice of proposed sale was filed under a Rule 10b5-1 trading plan adopted on December 11, 2024. This allows insiders to sell shares at predetermined times to avoid accusations of trading on inside information.
  • The filing also discloses a pattern of multiple sales by the same insider over the past three months, consistent with activity under a trading plan.
Topics:#SECFiling#InsiderTrading#Natera#NTRA#Form144#InsiderSell#StockMarket#Biotechnology

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.